- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01824888
Efficacy of JUC as Hand Rub Evaluated by Using European Standard 1500 (JUC)
December 10, 2014 updated by: John Yuen, The Hong Kong Polytechnic University
The Effectiveness and Efficacy of Using JUC Antimicrobial Spray for Controlling the Infection Transmission
JUC is a commercially available wound care spray.
It is evaluated for the efficacy when using as a hygienic hand rub following the protocol described in the European standard EN 1500:1997 "Chemical disinfectants and antiseptics - Hygienic handrub - Test method and requirement (phase 2/step 2)".
A crossover study to compare the JUC solution with 60% (v/v) propan-2-ol by using Escherichia coli K12 NCTC strain 10538 as test organism.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Before the intervention, the bactericidal activity of JUC was validated in accordance with the prEN 12054.
A total of 15 volunteers were recruited, hands were washed immediately prior to the intervention.
Then, both hands of each volunteer were immersed into a contamination fluid of E. coli.
Then, hand rub was performed with JUC or alcohol.
Culture samples were collected before and after the hand rub by rubbing the fingertips and thumb tips of each hand ont he base of a Petri dish containing appropriate medium.
The culture inoculation, incubation, appropriate dilutions, and colony count were performed.
Study Type
Interventional
Enrollment (Actual)
15
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Kowloon, Hong Kong
- PolyU Biomedical Science Laboratory
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- healthy and absence of significant illness
Exclusion Criteria:
- Visible wounds on hands
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Non-Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Control
Following standard one-minute handwashing, both hands were immersed up to the mid-metacarpals for 5 seconds into a contamination fluid containing E. coli.
Handrubs were performed by using 60% propan-2-ol into the cupped hands and rub vigorously for 30 seconds, the procedure was completed by a 5 seconds rinse of the fingers under running tap water and excess water was shaken off.
|
1.5 ml propan-2-ol rubbing on hands for 30 seconds, repeated twice
Other Names:
|
Experimental: JUC solution
Following standard one-minute handwashing, both hands were immersed up to the mid-metacarpals for 5 seconds into a contamination fluid containing E. coli.
Handrubs were performed by pouring 1.5 ml of JUC into the cupped hands and rub vigorously for 30 seconds, the procedure was completed by a 5 seconds rinse of the fingers under running tap water and excess water was shaken off.
|
1.5 ml JUC solution rubbing on hands for 30 seconds, repeated twice
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change of Colony forming units on hands from pre-value (baseline) to post-value
Time Frame: Pre-value (baseline) as 0 minutes: at the time after handwashing and before application of JUC or alcohol; Post-value at 5 minutes after the baseline: as after hand contamination, application of JUC or alcohol and drying of hands
|
Pre-value and post-value were collected by rubbing the fingertips and thumb tips of each hand for 1 minute on the base of a Petri dish containing medium.
Then the samples with appropriate dilutions were plated onto agar plates for incubation, and colony forming units of the plates were counted.
|
Pre-value (baseline) as 0 minutes: at the time after handwashing and before application of JUC or alcohol; Post-value at 5 minutes after the baseline: as after hand contamination, application of JUC or alcohol and drying of hands
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change of colony forming units on hands from baseline to 8 hours after hand rubbing with JUC
Time Frame: Pre-value (baseline) at 0 hour: at the first time after applicaiton of JUC and challenged by the bacteria; Post-values measured at each hour (1,2,3,4,5,6,7 and 8 hours) after the initial application of JUC and bacterial challenge at every hour
|
JUC was applied after handwashing, an invisible protective frame will be formed on treated hands.
Samples were collected for culture each hour after the challenge of the E. coli contamination fluid.Pre-value and post-value were collected by rubbing the fingertips and thumb tips of each hand for 1 minute on the base of a Petri dish containing medium.
Then the samples with appropriate dilutions were plated onto agar plates for incubation, and colony forming units of the plates were counted.
|
Pre-value (baseline) at 0 hour: at the first time after applicaiton of JUC and challenged by the bacteria; Post-values measured at each hour (1,2,3,4,5,6,7 and 8 hours) after the initial application of JUC and bacterial challenge at every hour
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Bactericidal efficacy of JUC and neutralizer
Time Frame: 1 day
|
Mixing the JUC with or without neutralizer with a fixed amount of E. coli to assess the bactericidal effects.
|
1 day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2012
Primary Completion (Actual)
August 1, 2012
Study Completion (Actual)
December 1, 2012
Study Registration Dates
First Submitted
March 22, 2013
First Submitted That Met QC Criteria
April 4, 2013
First Posted (Estimate)
April 5, 2013
Study Record Updates
Last Update Posted (Estimate)
December 11, 2014
Last Update Submitted That Met QC Criteria
December 10, 2014
Last Verified
December 1, 2014
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- JUC-001-EN1500
- 8-ZDA4 (Other Grant/Funding Number: PolyU-Grant-8-ZDA4)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infectious Disease Transmission
-
Shaare Zedek Medical CenterTerminatedInfectious Disease TransmissionIsrael
-
University of California, BerkeleyMinistry of Health and Social Welfare, Tanzania; International Initiative for... and other collaboratorsCompletedHIV Infections | Vertical Transmission of Infectious Disease
-
London School of Hygiene and Tropical MedicineEmory University; Imperial College London; Kenya Medical Research Institute; Kenya...CompletedHelminthiasis | Disease Transmission, Infectious | Nematode InfectionKenya
-
Duke UniversityCompleted
-
University of California, Los AngelesNational Institute of Mental Health (NIMH)UnknownSexually Transmitted Diseases | HIV | Safe Sex | Disease Transmission, InfectiousUnited States
-
University of North Carolina, Chapel HillAlbert Einstein College of Medicine; Abbott; Doris Duke Charitable Foundation; Université...RecruitingHepatitis B | Vertical Transmission of Infectious DiseaseCongo, The Democratic Republic of the
-
University of North Carolina, Chapel HillOhio State University; Kinshasa School of Public HealthCompletedHepatitis B | Vertical Transmission of Infectious DiseaseCongo, The Democratic Republic of the
-
Kahramanmaras Sutcu Imam UniversityCompletedCovid19 | Pregnancy Related | Neonatal Infection | Vertical Transmission of Infectious DiseaseTurkey
-
Ottawa Hospital Research InstituteCanadian Institutes of Health Research (CIHR)CompletedCovid19 | Pregnancy | Corona Virus Infection | SARS-CoV-2 | Infectious Disease Transmission, VerticalCanada
Clinical Trials on propan-2-ol
-
Academisch Medisch Centrum - Universiteit van Amsterdam...CompletedPancreatic Cancer | Esophageal Cancer | Rectal CancerNetherlands
-
Siemens Molecular ImagingCompletedCervical Cancer | Head and Neck Cancer | Lung Cancer | Rectal Cancer | Liver Cancer
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingAcute Myeloid LeukemiaUnited States
-
Maastricht Radiation OncologyTerminated
-
Maastricht Radiation OncologyTerminatedProstatic Neoplasms | Esophageal Neoplasms | Rectal Neoplasms | Brain Neoplasm, Primary | Neoplasm Metastases, BrainNetherlands
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
Olympus CorporationTerminated
-
Children's Oncology GroupNational Cancer Institute (NCI)RecruitingRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States, Canada
-
CerecinActive, not recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingChronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | IDH2 Gene Mutation | Acute Bilineal Leukemia | Acute Biphenotypic LeukemiaUnited States